Page last updated: 2024-10-30

mesalamine and Failure to Thrive

mesalamine has been researched along with Failure to Thrive in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Failure to Thrive: A condition of substandard growth or diminished capacity to maintain normal function.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hattar, LN1
Abraham, BP1
Malaty, HM1
Smith, EO1
Ferry, GD1
Braegger, CP1
Torresani, T1
Murch, SH1
Savage, MO1
Walker-Smith, JA1
MacDonald, TT1

Other Studies

2 other studies available for mesalamine and Failure to Thrive

ArticleYear
Inflammatory bowel disease characteristics in Hispanic children in Texas.
    Inflammatory bowel diseases, 2012, Volume: 18, Issue:3

    Topics: Adolescent; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Black or African American; Body Ma

2012
Urinary growth hormone in growth-impaired children with chronic inflammatory bowel disease.
    Journal of pediatric gastroenterology and nutrition, 1993, Volume: 16, Issue:1

    Topics: Adolescent; Aminosalicylic Acids; Child; Colitis, Ulcerative; Creatinine; Crohn Disease; Enzyme-Link

1993